Zimbabwe Medicine Regulator Tightens Border Screening to Intercept Counterfeit Drugs

The Medicines Control Authority of Zimbabwe announced it will immediately begin screening imported medicines at all national ports of entry. A report by the Daily News confirmed that this new border protocol aims to intercept counterfeit and substandard pharmaceuticals before they can enter the domestic market. This aggressive regulatory crackdown follows a massive surge in unregulated medical imports that bypassed official quality checks over the past year. Previously, the authority relied on post-market surveillance, which repeatedly failed to stop dangerous, unapproved drugs from reaching local pharmacies. Importers now face severe delays and increased compliance costs as border officials implement rigorous testing procedures that could trigger critical medicine shortages nationwide.